Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.
about
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports.Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
P2860
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Two dose investigation of the ...... nd global cerebral blood flow.
@en
type
label
Two dose investigation of the ...... nd global cerebral blood flow.
@en
prefLabel
Two dose investigation of the ...... nd global cerebral blood flow.
@en
P2093
P1433
P1476
Two dose investigation of the ...... nd global cerebral blood flow.
@en
P2093
Candace R Lewis
Franz X Vollenweider
Katrin H Preller
Lars Michels
Philipp Staempfli
Rainer Kraehenmann
P356
10.1016/J.NEUROIMAGE.2017.07.020
P407
P577
2017-07-12T00:00:00Z